News
Ozempic accidentally became a cultural phenomenon. The drug, first delivered to diabetes patients in 2017, had a huge impact ...
Meta (META) stock is dipping on reports that the company is restructuring its artificial intelligence (AI) unit for the ...
Novo Nordisk shares (DK:NOVO.B) (NVO) rose 5% in opening New York trade. The American depository receipts however have plunged 37% this year amid increased competition for its weight-loss drugs as ...
GoodRx is joining the GLP-1 action with an announcement Monday to begin selling both Novo Nordisk's GLP-1 drugs, Ozempic and ...
Hims & Hers saw 73% revenue growth, driven by subscriber gains and ARPU hikes. Read here for an in-depth investment analysis ...
US stocks opened mixed Friday as strong retail sales data offset hotter wholesale inflation, with UnitedHealth surging on ...
Berkshire Hathaway invests in UnitedHealth; FTC investigates Hims & Hers for advertising practices; U.S. health department ...
3d
TipRanks on MSNHere’s Why Wall Street Is Cautious on Hims & Hers Health Stock (HIMS)
Telehealth and wellness platform Hims & Hers Health ($HIMS) recently disappointed investors with its mixed second-quarter ...
Hims & Hers shares fall after a report says the FTC has investigated its cancellation policies and billing practices for over ...
Investing.com -- Hims & Hers Health (NYSE:HIMS) stock dropped 2.6% on Friday following reports that the Federal Trade Commission has been investigating the telehealth company's business practices for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results